Epstein Barr Virus Market is estimated to be US$ 2.48 billion by 2030 with a CAGR of 5.3% during the forecast period

The Epstein-Barr virus is one of eight types of human herpes viruses and is the most common. The Epstein–Barr virus (EBV) is the most prevalent cause of infectious mononucleosis and has been associated to a number of cancers, including gastric carcinoma, nasopharyngeal carcinoma, Burkitt lymphoma, Hodgkin lymphoma, lymphomas in immunocompromised patients, and multiple sclerosis. . Numerous studies have linked the Epstein–Barr virus to a variety of lymphatic cancers and lupus. Because the symptoms of this ailment are similar to those of other disorders, it can be difficult to diagnose. A blood test can identify antibodies to the Epstein-Barr virus. Epstein Barr virus market accounted for US$ 1.54 billion in 2020 and is estimated to be US$ 2.48 billion by 2030 and is anticipated to register a CAGR of 5.3%

The report " Epstein Barr Virus Market, By Test (Complete Blood Count Test, Monospot test and Others), By Application (Mononucleosis, Gastric Carcinoma, Multiple Sclerosis and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

• Atara Biotherapeutics announced in December 2018 that its lead candidate tab-cel (tabelecleucel) showed promising outcomes in patients with Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease who had previously had rituximab treatment. The FDA has also designated these medications as Breakthrough Therapy.
• The National Institutes of Health (NIH) awarded Vironika, LLC undisclosed cash in August 2018 to develop a lead drug that is a small molecule inhibitor for Epstein-Barr virus (EBV) lytic reactivation.

Analyst View:

Several universities are regularly involved in research and development for the development of novel monovaccines. Since 2017, the University of Kansas School of Engineering and Pharmacy has been studying the genetics of human immune responses in the hopes of developing a potent Epstein–Barr virus (EBV) vaccine. Rising research effort by various organizations for the development of innovative Epstein–Barr virus vaccines is expected to boost the worldwide Epstein–Barr virus vaccine market. Advances in serological testing for Epstein-Barr virus infection are driving the industry. Growing public awareness of therapeutic options, as well as technical advancements, are all propelling the market forward.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Epstein Barr Virus Market, By Test (Complete Blood Count Test, Monospot test and Others), By Application (Mononucleosis, Gastric Carcinoma, Multiple Sclerosis and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Market Insights from the report:

Epstein Barr virus market accounted for US$ 1.54 billion in 2020 and is estimated to be US$ 2.48 billion by 2030 and is anticipated to register a CAGR of 5.3%. The Global Epstein Barr Virus Market is segmented into test, application and region.

• By Test, the Epstein Barr Virus Market is segmented into Complete Blood Count Test, Monospot test and Others.
• By Application, the market is segmented in Mononucleosis, Gastric Carcinoma, Multiple Sclerosis and Others.
• By Region, the Epstein Barr Virus Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia-Pacific region holds the highest growth rate for the Epstein Barr Virus market

Competitive Landscape:

The key players operating in the Epstein Barr virus market includes Abbott, Bio-Rad Laboratories, Inc., Danaher Corporation, Cardinal Health Inc., Thermo Fischer Scientific Inc.,  and Others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com